Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

Nadler, Jeffrey P; Gathe, Joseph C; Pollard, Richard B; Richmond, Gary J; Liao, Qiming; Griffith, Sandy; Tracey Lancaster, C; Hernandez, Jaime E; Pappa, Keith A

doi:10.1186/1471-2334-3-10

BMC Infectious Diseases

Article metrics
Last updated: Fri, 19 Apr 2024 13:18:51 Z

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

Access & Citations

9760

Article Accesses
10

Web of Science
9

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com